Massive MS registry study to track rare side effects of common drugs
NCT ID NCT05767736
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 27 times
Summary
This study uses data from large MS registries to monitor the long-term safety of Vumerity and Tecfidera in about 10,500 people with multiple sclerosis. Researchers will compare serious side effects like infections and cancer among those taking these drugs versus other MS treatments. The goal is to better understand risks, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Cambridge, Massachusetts, 02142, United States
Conditions
Explore the condition pages connected to this study.